Please login to the form below

Not currently logged in
Email:
Password:

Porterhouse Medical launch strategic insight and research consultancy

Porterhouse Insights will offer solutions to pharmaceutical clients

Porterhouse Medical

Porterhouse Medical Group has launched a new strategic insight and research consultancy arm, Porterhouse Insights.

It will be headed up by Fabrice Allum, who moves to the Reading, Berkshire-based group from McCann Health, where he served as managing director, consulting.

Allum said: “Recent reflections on what I enjoyed most during my career journey led me to the conclusion that I needed to get back to addressing challenges for clients through the application of nimble and agile research.

“I thrive on building teams and collaborating with clients on generating actionable insights; as Porterhouse Insights, we are passionate about doing just that.”

The new agency will offer clients a full list of solutions including identification of unmet needs, market understanding, opportunity assessments, scenario planning, demand estimation, patient journey mapping, positioning, pricing and payer insights.

Jon Hallows, joint managing director, Porterhouse Medical Group, said: “Agencies that can identify challenges and provide tangible solutions to clients in a nimble and agile manner will be the agencies of the future.

“At Porterhouse Medical, we believe we can offer smarter medical communications by leveraging these research and insight services, as well as providing focused strategies through Porterhouse Insights as a stand-alone practice in its own right, with collaboration at the heart of what we do internally and externally.”

Article by
Gemma Jones

21st November 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics